Evidence for a selective antileukemic effect of cytosine arabinoside in chronic granulocytic leukemia
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 12 (6), 453-458
- https://doi.org/10.1016/0145-2126(88)90110-5
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- CML patients in blast crisis have breakpoints localized to a specific region of the BCRBlood, 1987
- Preferential inhibition by cytarabine of CFU-GM from patients with chronic granulocytic leukemiaCancer, 1987
- Low Dose Ara-C Administered by Continuous Subcutaneous Infusion: A Pharmacologic EvaluationCancer Drug Delivery, 1986
- The Philadelphia chromosome and Philadelphia chromosome mosaicism in chronic granulocytic leukemia.Journal of Clinical Oncology, 1986
- Clinical pharmacology of low-dose cytosine arabinosideBlood, 1985
- KARYOTYPIC CONVERSION IN Ph1-POSITIVE CHRONIC MYELOID LEUKÆMIA WITH COMBINATION CHEMOTHERAPYThe Lancet, 1979
- Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol)Blood, 1979
- Detection of specific sequences among DNA fragments separated by gel electrophoresisJournal of Molecular Biology, 1975